ENCEPHABOL

Negara: Indonesia

Bahasa: Bahasa Indonesia

Sumber: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Bahan aktif:

PYRITINOL

Tersedia dari:

MERCK TBK - Indonesia

INN (Nama Internasional):

PYRITINOL

Dosis:

80.5 MG

Bentuk farmasi:

SUSPENSI

Unit dalam paket:

DUS, 1 BOTOL @ 100 ML

Diproduksi oleh:

MERCK TBK - Indonesia

Tanggal Otorisasi:

2021-09-09

Karakteristik produk

Material name
: Encephabol Insert
Article No
: 10470505001V018
Dimension
: 148 x 225 mm
Material Quality
: HVS 60 gsm
Varnish & Finishing
: -
Barcode No.
: -
Pharmacode No.
: 111
Color
: Black
Color code
: Black
5 x 4 mm, 12 mm dari samping kiri
Packing condition, if applicable:
Length of alufoil
: -
Pcs per roll / sheet
: -
Pcs perbundle
: 25 pcs
Pcs pershipper
: -
Other condition
: Lipat 2, Lipat 3
(_eg. Folded leaflet_)
Revision History
: Old art no 10470505001V17
- OPI project.
Prepared by
: ferry
SPECIFICATION
File name : Encephabol Insert (10470505001V18)
REFERENCE DATE :
Encephalotropic, for oral use
Encephabol
®
Pyritinol Dihydrochloride Monohydrate
Encephabol is encephalotropic drug. It improves cerebral metabolism
and central cholinergic transmission and normalizes the cerebral
microcirculation.
COMPOSITIONS
Each Encephabol sugar coated tablet contains Pyritinol Dihydrochloride
Monohydrate 100 mg
One measuring spoon (5 ml) Encephabol liquid contains Pyritinol 80.5
mg corresponding to Pyritinol Dihydrochloride Monohydrate 100 mg
(one Encephabol sugar coated tablet). Sugar replacement : Sorbitol.
MODE OF ACTIONS
Encephabol exerts a beneficial effect on various regions of the
neuronal
metabolism, enhance the activity of the central cholinergic system
and protects the nerve cells in cerebral deficiencies, such as
hypoxia.
Encephabol normalizes the blood fluidity parameters and raises the
regional cerebral blood flow in ischemic areas.
Encephabol increases the vigilance by activation of cortical and
subcortical structures of the brain and improves the most important
clinical symptoms of impaired brain functions.
CLINICAL PARTICULARS
THERAPEUTIC INDICATIONS
Disturbances of cerebral circulations such as :
Craniocerebral traumas, condition after brain surgery, cerebrovascular
accidents and cerebral degenerative processes, prophylaxis of
postnarcotic confusional states, condition after cerebral anoxia (e.g.
following cardiac arrest).
POSOLOGY, METHOD AND DURATION OF ADMINISTRATION
COATED TABLET
Adults
: 2 coate